Home
>
Aurobindo Pharma Ltd Financials

Aurobindo Pharma Ltd Financial Statement

Aurobindo Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Dec 2023	Sep 2023	Jun 2023
Revenue	3,023.16	2,771.93	2,503.65
Operating Expense	2,210.34	2,123.58	1,968.44
Net Profit	623.78	415.74	335.95
Net Profit Margin	20.63	15	13.42
Earning Per Share	10.65	7.1	5.74
EBIDTA	886.33	655.39	543.47
Effective Tax Rate	16.85	21.16	21.73

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

3,023.16

2,210.34

623.78

20.63

10.65

886.33

16.85

2,771.93

2,123.58

415.74

7.1

655.39

21.16

2,503.65

1,968.44

335.95

13.42

5.74

543.47

21.73

Aurobindo Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	24,855.38	23,455.49	24,774.62
Operating Expenses Annual	21,136.74	19,068.72	19,441.22
Operating Profit Annual	3,997.56	4,547.9	8,473.47
Interest Annual	140.48	48.64	74.49
Depreciation	759.57	719.57	687.36
Net Profit Annual	1,927.5	2,648.15	5,334.84
Tax Annual	684.85	725.63	2,009.77

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

24,855.38

21,136.74

3,997.56

140.48

759.57

1,927.5

684.85

23,455.49

19,068.72

4,547.9

48.64

719.57

2,648.15

725.63

24,774.62

19,441.22

8,473.47

74.49

687.36

5,334.84

2,009.77

Aurobindo Pharma Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	4,168.92	5,326.66	2,769.23
Cash Flow from Operations	2,386.75	5,016.48	3,329.05
Cash Flow from Investing	-3,977.81	-3,211.36	596.57
Cash Flow from Financing	1,814.41	-2,969.27	-1,364.94
Cash Flow at the End	4,392.27	4,162.51	5,329.91

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

4,168.92

2,386.75

-3,977.81

1,814.41

4,392.27

5,326.66

5,016.48

-3,211.36

-2,969.27

4,162.51

2,769.23

3,329.05

596.57

-1,364.94

5,329.91

Aurobindo Pharma Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	16.08	19.39	22.84
PBIT Margin (%)	11.08	14.59	18.58
PBT Margin (%)	10.93	13.97	18.19
Net PROFIT Margin (%)	9.62	12.89	19.67
Return On Networth / Equity (%)	7.5	11.38	17.59
Return On Networth /Employed(%)	9.18	12.41	18.29
Return On Assets (%)	7.98	10.95	19.28
Total Debt / Equity(X)	0.17	0.18	0.27
Asset Turnover Ratio (%)	0.83	0.85	0.98

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

16.08

11.08

10.93

9.62

7.5

9.18

7.98

0.17

0.83

19.39

14.59

13.97

12.89

11.38

12.41

10.95

0.18

0.85

22.84

18.58

18.19

19.67

17.59

18.29

19.28

0.27

0.98

Aurobindo Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	11,917.3	11,341.73	10,006.22
Total Current Assets Annual	21,545.67	18,122.69	19,823.51
Non Current Assets Annual	18,344.32	15,799.03	14,030.48
Total Shareholders Funds Annual	26,839.85	24,575.98	21,929.87
Total Assets Annual	39,889.99	33,921.72	33,853.99

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

11,917.3

21,545.67

18,344.32

26,839.85

39,889.99

11,341.73

18,122.69

15,799.03

24,575.98

33,921.72

10,006.22

19,823.51

14,030.48

21,929.87

33,853.99

Aurobindo Pharma Ltd Earning Calls

Dec 2023

EPS beaten by 0.38 %

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

Get Your FAQs Right

What is Aurobindo Pharma Ltd's share capital?

As of May 20, 2024, Aurobindo Pharma Ltd has a market capitalization of 30,351.62 Cr. Value Research classifies it as a Large-Cap company.

Is Aurobindo Pharma Ltd debt-free?

Yes, Aurobindo Pharma Ltd is debt-free with a debt-to-equity ratio of 0.20.

What is Aurobindo Pharma Ltd's total revenue?

In FY 2023, Aurobindo Pharma Ltd recorded a total revenue of approximately 24,617.13 Cr marking a significant milestone in the company's financial performance.

What is the future growth of Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.3% and 0.0% annually, respectively..

What is the PE Ratio of Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd's current PE ratio is 15.75.

What is Aurobindo Pharma Ltd's Return on Capital Employed (ROCE)?

Aurobindo Pharma Ltd's ROCE averaged 12.6% from the FY ending March 2021 to 2023, with a median of 12.5%. It peaked at 16.8% in March 2021, reflecting strong capital efficiency over the period..

What is the latest EBIT (Earnings Before Interest and Taxes) of Aurobindo Pharma Ltd?

Aurobindo Pharma Ltd's latest EBIT is Rs. 2,752.98 Cr, surpassing the average EBIT of Rs. 4,530.82 Cr over the 5 years..